Future of the Global Coronary Pressure Market: Growth Projections and Key Trends (2025-2034)
The coronary pressure market size is expected to see strong growth in the next few years. It will grow to $27.95 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to the rising prevalence of coronary artery disease (CAD), the growing geriatric population, the increasing adoption of minimally invasive procedures, and increasing awareness about early disease detection. Major trends in the forecast period include technological advancements, increased cost-effective treatment, improved healthcare access, and launches of new products and services.
Get Your Free Sample of The Global Coronary Pressure Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18801&type=smp
Which major factors have contributed to the expansion of the coronary pressure market?
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the coronary pressure market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, hypertension, and heart failure, often linked to lifestyle factors and genetics. Cardiovascular disease rates are on the rise owing to several factors, such as unhealthy diets, sedentary lifestyles, and increasing obesity. Coronary pressure devices help in assessing and managing cardiovascular diseases by measuring coronary artery pressures, guiding treatment decisions, and improving outcomes for patients with heart conditions. For instance, in August 2022, according to a study published in the Journal of the American College of Cardiology, a US-based organization, all four cardiovascular risk factors are anticipated to rise among the general U.S. population between 2025 and 2060, with diabetes showing the biggest percentage increase of 39.3%, followed by dyslipidemia with an increase of 27.6%, hypertension with an increase of 25.1%, and obesity with an increase of 18.3%. The researchers discovered that heart failure (33.4%) and ischemic heart disease (30.7%) had the biggest anticipated increases in rates, followed by heart attack (16.9%) and stroke (33.8%). Therefore, the increasing prevalence of cardiovascular diseases is driving the coronary pressure market.
How is the coronary pressure market segmented?
The coronary pressure market covered in this report is segmented –
1) By Device: Sphygmomanometer, Automated Blood Pressure Monitor, Blood Pressure (BP) Transducers, Ambulatory Blood Pressure Monitor
2) By Technology: Digital, Aneroid, Wearable
3) By End User: Hospitals, Cardiac Care Centers, Ambulatory Centers And Homecare, Academic Institutes
Subsegments:
1) By Sphygmomanometer: Manual Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer
2) By Automated Blood Pressure Monitor: Digital Blood Pressure Monitors, Wrist Blood Pressure Monitors, Upper Arm Blood Pressure Monitors
3) By Blood Pressure (BP) Transducers: Invasive BP Transducers, Non-Invasive BP Transducers
4) By Ambulatory Blood Pressure Monitor: Single-Channel Ambulatory BP Monitors, Multi-Channel Ambulatory BP Monitors
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/coronary-pressure-global-market-report
Who are the top competitors in the coronary pressure market?
Major companies operating in the coronary pressure market are Cardinal Health Inc., General Electric Company, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips, Baxter International Inc., Boston Scientific Corporation, Philips Healthcare, Terumo Corporation, Omron Corporation, Edwards Lifesciences, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, AtriCure, Rossmax, A&D Medical, St. Jude Medical, HeartWare International
Which key trends are expected to influence the coronary pressure market in the coming years?
Major companies operating in the coronary pressure market are focusing on developing innovative products, such as drug-eluting coronary stent systems, to enhance treatment efficacy, reduce restenosis rates, and improve long-term patient outcomes. Drug-eluting coronary stent systems are medical devices designed to treat coronary artery disease by delivering medication directly to the artery through a stent, helping to prevent restenosis (re-narrowing of the artery) and improving long-term vascular health. For instance, In May 2022, Medtronic, an Ireland-based medical device company, received FDA approval for its latest generation Onyx Frontie drug-eluting stent. This innovative system is designed to enhance the treatment of coronary artery disease by delivering medications that help prevent restenosis, or the re-narrowing of the artery after stent placement. The new stent system incorporates advanced technologies aimed at improving patient outcomes and reducing complications associated with coronary interventions.
Which regional trends are influencing the coronary pressure market, and which area dominates the industry?
North America was the largest region in the coronary pressure market in 2024. The regions covered in the coronary pressure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Coronary Pressure Market Report 2025 Offer?
The coronary pressure market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Coronary pressure refers to the pressure within the coronary arteries, which deliver blood and oxygen to the heart muscle. It is a vital metric for evaluating the sufficiency of blood flow and oxygen supply to the heart. Influenced by factors such as heart rate, blood volume, and arterial resistance, monitoring coronary pressure is essential in diagnosing and managing coronary artery disease.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18801
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment